By Gift BritonFor the first time, infants younger than 28 days (neonates) can safely receive Dolutegravir (DTG), one of the most effective and widely used HIV drugs worldwide.Since the World Health ...

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

There is a pervasive sense of fear — of losing access to critical health care services and of livelihoods lost,” CFK Africa ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Invite the Ukrainian president to the heartland of America. Show him and the world that we categorically denounce the treatment he received.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

The cancellation of USAID contracts has threatened critical global health research. Plus, new guidance to prevent HIV in ...